Ultrasound enhanced gene therapy: Development of ultrasonic methods of gene transfection for cardiovascular system.
Ultrasound enhanced gene therapy: Development of ultrasonic methods of gene transfection for cardiovascular system.
批准号:
14570709
负责人:
KOMAMURA Kazuo
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ultrasound-triggered microbubble destruction has been proposed as a means of targeting gene therapy to specific organs. Successful reporter gene expression using this approach has been reported. However, quantification of therapeutic gene products with this method has not been elucidated yet in cardiovascular cells or tissues. We examined the dose-response relations among the amount of gene, microbubble concentration and the duration of incubation using neonatal rat cardiomyocytes. We employed expression plasmid of Escheririchia Coli β-Galactosidase gene, expression plasmid of rat hepatocyte growth factor (HGF) gene containing CMV-β actin hybrid promoter, and cultured rat neonatal cardiomyocytes for in vitro experimental setups. We used continuous-wave Doppler ultrasound with frequency of 2.5MHz and maximal intensity of 0.5W/cm^2 because of clinical relevance.1.Repetitive exposure to ultrasound-triggered galactose/palmitic acid microbubble destruction may yield efficient transfection of genes to cardiomyocytes.2.Using catheter in the rat left ventricular cavity with precordial ultrasound irradiation, we examined the feasibility of luciferase gene transfection into the myocardium. Luciferase activity was detected only in the anterior myocardium, and the level of expression was similar to that in HUVEC cells for in vitro experiments for transfection, suggesting difficulty to transfect beyond the endothelial barrier.3.We examined the feasibility of luciferase gene transfection into the myocardium with precordial ultrasound irradiation in the setting of intravenous administration of gene and microbubble. We detected no expression of luciferase in the myocardium, and some expression in the liver.4.Taken together, we might as well (1)develop more specific gene targeting method for myocardial transfection with modifying enhancer/promoter ; and (2)improve microbubble shells with higher affinity for both plasmid-gene and myocardial cell membrane.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Treatment of dilated cardiomyopathy with electration of hepatocyte growth factor gene into skeletal muscle
将肝细胞生长因子基因植入骨骼肌治疗扩张型心肌病
DOI:
--
发表时间:
2004
期刊:
Hypertension 44(3)
影响因子:
--
作者:
[Komamura K]
通讯作者:
Komamura K
超音波遺伝子治療
超声基因治疗
DOI:
--
发表时间:
2003
期刊:
超音波TECHNO 15(3)
影响因子:
--
作者:
[駒村和雄]
通讯作者:
駒村和雄
DOI:
10.1023/a:1027352703783
发表时间:
2003-07-01
期刊:
CARDIOVASCULAR DRUGS AND THERAPY
影响因子:
3.4
作者:
[Komamura, K, Shirotani-Ikejima, H, Miyata, T]
通讯作者:
Miyata, T
Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant α-galactosidase A
通过重组 α-半乳糖苷酶 A 治疗可改善法布里病患者的心脏肥大和心室功能
DOI:
--
发表时间:
2004
期刊:
Heart 90(6)
影响因子:
--
作者:
[Nishikimi T, Mori Y, Kobayashi N, Tadokoro K, Wang X, Akimoto K, Yoshihara F, Kangawa K, Matsuoka H, Komamura K]
通讯作者:
Komamura K
Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant alpha-galactosidase A.
通过重组 α-半乳糖苷酶 A 治疗可改善法布里病患者的心脏肥大和心室功能。
DOI:
--
发表时间:
2004
期刊:
Heart. 90(6)
影响因子:
--
作者:
[Komamura, K., Higashi, M., Yamada, N.]
通讯作者:
N.
共 7 条
Beneficial effects of appendicular thermal therapy on endotherial and cardiac functions of the patients with end-stage heart failure fitted with an extracorporeal left ventricular assist device
-
批准号:19500469
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:KOMAMURA Kazuo
-
依托单位:
Novel Therapy for Heart Failure of cardiomyopathic Hamster with Gene Transfection of Hepatocyte Growth Factor
-
批准号:11670729
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:1999
-
负责人:KOMAMURA Kazuo
-
依托单位:
海外基金